Status: current, Defined. Date: 31-Dec 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4502771000168110 | Scenesse (afamelanotide 16 mg) implant (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4502781000168113 | Scenesse 16 mg implant | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Scenesse 16 mg implant | Is a | Scenesse | true | Inferred relationship | Some | ||
| Scenesse 16 mg implant | Is a | afamelanotide 16 mg implant | true | Inferred relationship | Some | ||
| Scenesse 16 mg implant | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Scenesse 16 mg implant | has manufactured dose form | implant | true | Inferred relationship | Some | ||
| Scenesse 16 mg implant | has unit of use | implant | true | Inferred relationship | Some | 1519412464 | |
| Scenesse 16 mg implant | has intended active ingredient | afamelanotide | true | Inferred relationship | Some | 336874069 | |
| Scenesse 16 mg implant | has Australian BoSS | afamelanotide | true | Inferred relationship | Some | 336874069 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Scenesse 16 mg implant, 1 | has TPUU | True | Scenesse 16 mg implant | Inferred relationship | Some | 1584098255 |
| Scenesse 16 mg implant, 1, vial | has TPUU | True | Scenesse 16 mg implant | Inferred relationship | Some | 995847919 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR